Home Article Medtronic CGM gets nod from FDA

Medtronic CGM gets nod from FDA

Medtronic CGM gets nod from FDA

Also Noted

Default Author Head Shot

By HME News Staff

Updated 12:24 PM CDT, Wed August 7, 2024

MINNEAPOLIS – Medtronic’s Simplera continuous glucose monitor (CGM) has received regulatory approval from the U.S. Food and Drug Administration. Simplera, the company's first disposable, all-in-one continuous glucose monitor, is half the size of its previous CGMs. The Medtronic Simplera platform includes the Simplera CGM, which is designed to be used as part of a Smart MDI system with the InPen smart insulin pen; and the Simplera Sync sensor, which is designed to be integrated with the MiniMed 780G system. The Simplera CGM and Simplera Sync sensor, which are CE Marked in Europe, launched earlier this year.

Comments

To comment on this post, please log in to your account or set up an account now.